T cell receptor alpha chain variable region family 2 member D protein

The **T cell receptor alpha chain variable region family 2 member D protein** is a putative gene product representing one member within the diverse set of human **T cell receptor (TCR) alpha chain variable regions**[2]. The canonical structure of a functional human αβ-TCR consists of an α-chain and a β-chain heterodimer anchored in the membrane. Each chain contains highly diverse *variable domains*, which are generated by somatic recombination from multiple gene segments—variable (V), joining (J), and constant (C)—to enable recognition of a vast array of antigens presented by major histocompatibility complex molecules[1][3]. The "family 2 member D" nomenclature suggests it is one variant within the Vα gene segment subfamilies described in humans[2]. These segments contribute diversity at both sequence and structural levels, allowing each mature T lymphocyte clone its unique antigen specificity. However, there is no evidence that "T cell receptor alpha chain variable region family 2 member D" refers to an established therapeutic target or that it has been individually characterized outside its role as part of generic antigen recognition machinery. Most research focuses on entire families/subfamilies rather than single members due to their redundancy and combinatorial diversity[1][3]. This entry appears overly granular for typical drug discovery/targeting purposes; thus, **the name likely does not correspond to an accepted standalone therapeutic target**, nor does it have recognized clinical relevance as an isolated entity. > The Vα gene segments belong to different subfamilies... each containing from one to seven members... Comparisons indicate high variability across these regions without obvious hypervariable regions.[2] In summary: This molecule is best understood as one genetic building block among many contributing sequence diversity within human αβ-T-cell receptors. It is *not* considered a distinct druggable target. --- If you need structured information on more widely recognized targets such as "T cell receptor," "CD3," or specific engineered receptors used clinically, please specify.

Other names

TCR alpha variable region family 2 member DTRAV2D (inferred, not standard)T cell receptor V alpha 2.4 (possible, but not confirmed in sources)